104 related articles for article (PubMed ID: 9208137)
1. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation.
Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
Br J Pharmacol; 1997 Jun; 121(4):705-10. PubMed ID: 9208137
[TBL] [Abstract][Full Text] [Related]
2. Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation.
Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
Eur J Pharmacol; 1997 Sep; 334(1):49-53. PubMed ID: 9346327
[TBL] [Abstract][Full Text] [Related]
3. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.
Barelli H; Dive V; Yiotakis A; Vincent JP; Checler F
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):621-5. PubMed ID: 1332678
[TBL] [Abstract][Full Text] [Related]
5. Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo.
Vincent B; Dive V; Yiotakis A; Smadja C; Maldonado R; Vincent JP; Checler F
Br J Pharmacol; 1995 Jul; 115(6):1053-63. PubMed ID: 7582503
[TBL] [Abstract][Full Text] [Related]
6. S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase.
Barelli H; Petit A; Hirsch E; Wilk S; De Nanteuil G; Morain P; Checler F
Biochem Biophys Res Commun; 1999 Apr; 257(3):657-61. PubMed ID: 10208839
[TBL] [Abstract][Full Text] [Related]
7. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of endopeptidase 24.16 by dipeptides.
Dauch P; Vincent JP; Checler F
Eur J Biochem; 1991 Dec; 202(2):269-76. PubMed ID: 1761032
[TBL] [Abstract][Full Text] [Related]
9. Fluorimetric assay of the neurotensin-degrading metalloendopeptidase, endopeptidase 24.16.
Dauch P; Barelli H; Vincent JP; Checler F
Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):421-6. PubMed ID: 1747117
[TBL] [Abstract][Full Text] [Related]
10. Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors.
Yiallouros I; Vassiliou S; Yiotakis A; Zwilling R; Stöcker W; Dive V
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):375-9. PubMed ID: 9531473
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.
Skidgel RA; Erdös EG
Peptides; 2004 Mar; 25(3):521-5. PubMed ID: 15134871
[TBL] [Abstract][Full Text] [Related]
13. Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase.
Yiotakis A; Lecoq A; Nicolaou A; Labadie J; Dive V
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):323-7. PubMed ID: 7945258
[TBL] [Abstract][Full Text] [Related]
14. Development of the first potent and selective inhibitor of the zinc endopeptidase neurolysin using a systematic approach based on combinatorial chemistry of phosphinic peptides.
Jirácek J; Yiotakis A; Vincent B; Checler F; Dive V
J Biol Chem; 1996 Aug; 271(32):19606-11. PubMed ID: 8702656
[TBL] [Abstract][Full Text] [Related]
15. Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum.
Barelli H; Fox-Threlkeld JE; Dive V; Daniel EE; Vincent JP; Checler F
Br J Pharmacol; 1994 May; 112(1):127-32. PubMed ID: 8032633
[TBL] [Abstract][Full Text] [Related]
16. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of human endopeptidase 3.4.24.16. Comparison with the porcine counterpart indicates a unique cleavage site on neurotensin.
Vincent B; Vincent JP; Checler F
Brain Res; 1996 Feb; 709(1):51-8. PubMed ID: 8869556
[TBL] [Abstract][Full Text] [Related]
18. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.
Shrimpton CN; Abbenante G; Lew RA; Smith I
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):351-6. PubMed ID: 10620512
[TBL] [Abstract][Full Text] [Related]
20. Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum.
Barelli H; Vincent JP; Checler F
Eur J Biochem; 1988 Aug; 175(3):481-9. PubMed ID: 3409880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
